| Revenue | DKK 607K | -10% |
| EBITDA | DKK -221K | +56% |
| Net profit | DKK -261K | +44% |
| Total assets | DKK 2,3M | -14% |
| Equity | DKK 487K | -35% |
| Employees | 4 | — |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | -136 | -623 | 819 | 1.086 | 2.190 | 377 | 674 | 607 |
| Staff expenses | -69 | -693 | -660 | -933 | -1.312 | -745 | -1.175 | -828 |
| EBITDA | -205 | -1.317 | 159 | 153 | 878 | -368 | -501 | -221 |
| Depreciation & amort. | -7 | -34 | -48 | -59 | -52 | -25 | -17 | -11 |
| EBIT | -213 | -1.351 | 111 | 94 | 826 | -393 | -518 | -233 |
| Net financials | -1 | -4 | -37 | -16 | -37 | -34 | -82 | -98 |
| Profit before tax | -213 | -1.354 | 74 | 78 | 789 | -427 | -600 | -331 |
| Tax | -47 | -297 | 65 | 18 | 175 | -90 | -131 | -70 |
| Net profit | -167 | -1.057 | 9 | 60 | 614 | -338 | -469 | -261 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 243 | 1.155 | 1.199 | 2.040 | 2.467 | 2.492 | 2.689 | 2.302 |
| Equity | -117 | 870 | 879 | 939 | 1.554 | 1.216 | 747 | 487 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 360 | 285 | 321 | 1.101 | 913 | 1.276 | 1.942 | 1.815 |
| Total debt | 360 | 285 | 321 | 1.101 | 913 | 1.276 | 1.942 | 1.815 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MS Management | Management | 2017 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Chrysopoeia ApS | Company | 66.7% | 66.7% | 2017 |
Sangild Invest ApS | Company | 15.0% | 15.0% | 2019 |
| Person | Role here | Other companies |
|---|---|---|
| Magnus Stephensen | Management | 0 companies |